Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model

Cancer Letters

Volumn 150, Issue 1, 2000, Pages 111-117

  Chen, Bin ^a   De Witte, Peter A ^a  

^a K   (Belgium)

Author keywords

Antitumor; Biodistribution; Hypericin; Photodynamic therapy

Indexed keywords

HYPERICIN; PHOTOFRIN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; FEMALE; LYMPHOMA; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INJECTIONS, INTRAPERITONEAL; KIDNEY; LIVER; MICE; MICE, INBRED DBA; MUSCLES; NEOPLASMS, EXPERIMENTAL; PERYLENE; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; SKIN; SPLEEN; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE DISTRIBUTION; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0034089261     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00381-X     Document Type: Article

References (30)

1. Henderson B.W., Dougherty T.J. How does photodynamic therapy work? Photochem. Photobiol. 55:1992;145-157.
2. Schuitmaker J.J., Baas P., van Leengoed H.L., van der Meulen F.W., Star W.M., van Zandwijk N. Photodynamic therapy: a promising new modality for the treatment of cancer. J. Photochem. Photobiol. B. 34:1996;3-12.
3. Levy J.G. Photodynamic therapy. Trends Biotechnol. 13:1995;14-18.
4. Duran N., Song P.S. Hypericin and its photodynamic action. Photochem. Photobiol. 43:1986;677-680.
5. Lavie G., Mazur Y., Lavie D., Meruelo D. The chemical and biological properties of hypericin - a compound with a broad spectrum of biological activities. Med. Res. Rev. 15:1995;111-119.
6. Racinet H., Jardon P., Gautron R. Formation d'oxygène singulet 1 delta g photosensibiliséepar 1'hypericine, étude cinétique en milieu micellaire non ionique. J. Chim. Phys. 85:1988;971-977.
7. Meruelo D., Lavie G., Lavie D. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA. 85:1988;5230-5234.
8. Vandenbogaerde A.L., Cuveele J.F., Proot P., Himpens B.E., Merlevede W.J., de Witte P.A. Differential cytotoxic effects induced after photosensitization by hypericin. J. Photochem. Photobiol. B. 38:1997;136-142.
9. Vandenbogaerde A.L., Delaey E.M., Vantieghem A.M., Himpens B.E., Merlevede W.J., de Witte P.A. Cytotoxicity and antiproliferative effect of hypericin and derivatives after photosensitization. Photochem. Photobiol. 67:1998;119-125.
10. English D.S., Doyle R.T., Petrich J.W., Haydon P.G. Subcellular distributions and excited-state processes of hypericin in neurons. Photochem. Photobiol. 69:1999;301-305.
11. Assefa Z., Vantieghem A., Declercq W., Vandenabeele P., Vandenheede J.R., Merlevede W., de Witte P., Agostinis P. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J. Biol. Chem. 274:1999;8788-8796.
12. Vantieghem A., Assefa Z., Vandenabeele P., Declercq W., Courtois S., Vandenheede J.R., Merlevede W., de Witte P., Agostinis P. Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett. 440:1998;19-24.
13. Thomas C., Macgill R.S., Neill P., Pardini R.S. The in vitro and in vivo photoinduced antineoplastic activity of hypericin. Proc. Am. Assoc. Cancer Res. 33:1992;500.
14. Vandenbogaerde A.L., Geboes K.R., Cuveele J.F., Agostinis P.M., Merlevede W.J., de Witte P.A. Antitumour activity of photosensitized hypericin on A431 cell xenografts. Anticancer Res. 16:1996;1619-1625.
15. Falk H., Meyer J., Oberreiter M. A convenient semi-synthetic route to hypericin. Monatsh. Chem. 124:1993;339-341.
16. Canti G., Nicolin A., Cubeddu R., Taroni P., Bandieramonte G., Valentini G. Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors. Cancer Lett. 125:1998;39-44.
17. Fingar V.H., Henderson B.W. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photochem. Photobiol. 46:1987;837-841.
18. Faustino M.A., Neves M.G., Vicente M.G., Cavaleiro J.A., Neumann M., Brauer H.D., Jori G. Meso-tetraphenylporphyrin dimer derivative as a potential photosensitizer in photodynamic therapy. Photochem. Photobiol. 66:1997;405-412.
19. Delaey E.M., Vandenbogaerde A.L., Agostinis P., de Witte P.A. Confluence dependent resistance to photo-activated hypericin in HeLa cells. Int. J. Oncol. 14:1999;759-763.
20. Schabel F.M. Test systems for evaluating the antitumor activity of nucleoside analogues. Walker R.T., Eckstein E., De Clercq F. Nucleoside Analogues - Chemistry, Biology and Medical Applications. 1979;363-394 Plenum, New York.
21. Bellnier D.A., Ho Y.K., Pandey R.K., Missert J.R., Dougherty T.J. Distribution and elimination of Photofrin II in mice. Photochem. Photobiol. 50:1989;221-228.
22. Kerb R., Brockmoller J., Staffeldt B., Ploch M., Roots I. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin. Antimicrob. Agents Chemother. 40:1996;2087-2093.
23. Chung P.S., Saxton R.E., Paiva M.B., Rhee C.K., Soudant J., Mathey A., Foote C., Castro D.J. Hypericin uptake in rabbits and nude mice transplanted with human squamous cell carcinomas: study of a new sensitizer for laser phototherapy. Laryngoscope. 104:1994;1471-1476.
24. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90:1998;889-905.
25. Gomer C.J., Ferrario A. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res. 50:1990;3985-3990.
26. Veenhuizen R., Oppelaar H., Ruevekamp M., Schellens J., Dalesio O., Stewart F. Does tumour uptake of Foscan determine PDT efficacy? Int. J. Cancer. 73:1997;236-239.
27. Soncin M., Busetti A., Reddi E., Jori G., Rither B.D., Kenney M.E., Rodgers M.A. Pharmacokinetic and phototherapeutic properties of axially substituted Si(IV)-tetradibenzobarreleno-octabutoxyphthalocyanines. J. Photochem. Photobiol. B. 40:1997;163-167.
28. Ferrario A., Gomer C.J. Lethality in mice following localized photodynamic therapy. Proc. SPIE. 1065:1989;50-53.
29. Ferrario A., Gomer C.J. Systemic toxicity in mice induced by localized porphyrin photodynamic therapy. Cancer Res. 50:1990;539-543.
30. Tije A.J., Wieman T.J., Taber S.W., Tseng M.T., Cerrito P.B., Jansen J.M., Guo H.H., Fingar V.H. Analysis of pulmonary microvasculature changes after photodynamic therapy delivered to distant sites. Photochem. Photobiol. 69:1999;494-499.